US 9932372
Designer peptide-based PCV2 vaccine
granted A61KA61K2039/552A61K2039/55566
Quick answer
US patent 9932372 (Designer peptide-based PCV2 vaccine) held by United Biomedical, Inc. expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Biomedical, Inc.
- Grant date
- Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/552, A61K2039/55566, A61K2039/6031, A61K39/12